Monday, December 15, 2014

Government Drug Pricing Forum

Government Drug Pricing Forum
February 11-13, 2015
Embassy Suites Washington DC Convention Center, Washington. DC

With the increase in complexity of government pricing and contracting, the Conference Forum is no longer holding its Medicaid Rebate Summit. Instead, it is expanding its coverage and presenting the Government Drug Pricing Forum (GDP). The GDP Forum will cover changes in MDRP, 340B, Tricare and Medicaid Managed Care. It specifically addresses the AMP Final Rule, AMP-based FULs, proposed HRSA guidance, rise of contract pharmacies, and new state reporting requirements impact government and commercial contracting rules and operations. This event brings together CMS, FDA, IRS, HRSA, States and OIG to address how to be compliant with separate agency requirements.

Register today! Drug Channels readers receive a 15% discount with code DC15.

Featured Speakers include:
  • Lori Reilly, PhRMA
  • Laurel Todd, BIO
  • Don Bell, National Association Chain Drug Store (NACDS)
  • Ann Maxwell, Office of Evaluation and Inspections, Office of Inspector General
  • Andrew Wilson, McKesson
  • Alice Valder Curran, Hogan Lovells
  • John Shakow, King & Spaulding
  • Kathleen Black, Pfizer
  • George Kenny, Genentech
  • Stephanie Kupski, Iroko Pharmaceuticals
  • Ed McAdam, Daiichi Sankyo
  • Jay McKinley, Dendreon
  • Lorraine Moccio, Johnson & Johnson
Conference Topics
  • Healthcare Trends and Policy Expectations: From ACOs and AMP to Contract Pharmacies
  • New State Reporting Requirements and Tricare Contracting
  • Drug Channel Contracting Strategies
  • Compliant Government Pricing Programs
February 11th Workshop Choices
Register today! Drug Channels readers receive a 15% discount with code DC15.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...